Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07574255
Starting soon Observational

3D-US Construct on Volumetric Assessment of Lung Disease & Clinical Application

NCT07574255 · tracked via the Priya Life Science Taiwan tracker
Sponsor
National Taiwan University Hospital
Phase
Observational
Started
2026-05-30
Last updated
2026-05-07

Condition(s) studied

Lung UltrasoundLung Cancer (Diagnosis)Peripheral Lung LesionsUltrasound Assessment

Study summary

The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. The primary question our study aims to answer is:

Whether the 3D ultrasound morphology can reflect lung disease entities? Whether the 3D volumetric follow-up protocol can be standardised to reflect lung disease status?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Participants suspect with lung lesions referred for ultrasound workup Exclusion Criteria: * Participants aged \< 18 years * Participants refusal * Participants with implanted metal in scanning area interfering data collection * Participants who cannot perform breath holding for at least 1 second

Primary outcome measure(s)

  • volume of measured lesion — from enrollment, every 6 weeks until 24th week
    Standard volume will be defined by computed tomography measurement, and the ultrasound 3D-volmetric result would be compared

Trial sites (1)

FacilityCityRegionStatus
National Taiwan University Hospital Taipei Taiwan

More National Taiwan University Hospital trials in Taiwan

Correlation Between Soft Tissue Displacement and Functional Performance in Orthopedic Patients Starting soon
Home-based Cardiac Rehabilitation With Spot-jogging Active, not recruiting
Comparison of Needlescopic vs. Conventional Laparoscopic Adrenalectomy for Tumor Less Than 4 cm Starting soon
AI Based Physiotherapy 3- and 9-Month Follow-Up in Oral Cancer Patients Recruiting
Deep Versus Standard Prolonged Intermittent Theta Burst Stimulation for Depression Enrolling by invitation

Other trials for the same condition

The Effects of Low Intensity Endurance Exercise on Improving Mitochondrial Function, Cell Bioelectrical Impedance Phase Angle, Fatigue and Quality of Life in Lung Cancer Patients With Cancer-related Fatigue Recruiting
The Effects of Low-Intensity Endurance Exercise on Improving Fatigue, Sleep, Quality of Life, Mitochondrial Function, Cellular Bioelectrical Impedance Phase Angle, and Predictors of Exercise Adherence in Patients With Lung Cancer Recruiting
Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy Recruiting
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and Monitoring Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07574255 on ClinicalTrials.gov ↗ ← All trials in Taiwan